Last updated: May 30, 2026
Doryx MPC is a doxycycline hyclate delayed-release tablet brand marketed by Padagis LLC. Publicly available, citable supplier-level detail on the contract manufacturing chain (API makers and finished-dose manufacturers for each market) is not provided in the available information base, so supplier identification cannot be completed to a standard suitable for licensing, litigation, or R&D vendor qualification.
What companies supply Doryx MPC tablets and doxycycline hyclate delayed-release product?
No supplier names can be stated from the available information.
Is Doryx MPC manufactured by Padagis or a contract manufacturer?
No citable manufacturing-source details are available.
What are the likely supply links for delayed-release doxycycline products?
No citable mapping of API suppliers, excipient suppliers for the MPC (microparticle coating) system, or finished-dose contract manufacturers can be provided.
What patents protect Doryx MPC manufacturing, formulations, or coatings?
No patent estate can be stated from the available information.
What is the Orange Book status of Doryx MPC and what does it imply for supplier sourcing?
No Orange Book listing or applicant/holder details can be stated from the available information.
Which distributors supply Doryx MPC to pharmacies and hospitals?
No distributor or wholesaler network mapping can be stated from the available information.
What generic or authorized generic risks exist for Doryx MPC, and how does that affect suppliers?
No Paragraph IV or ANDA/Bioequivalence landscape can be stated from the available information.
How does Doryx MPC supply compare with other doxycycline delayed-release brands?
No brand-to-brand sourcing comparison can be completed from the available information.
Key Takeaways
- Supplier-level identification for Doryx MPC (API and finished-dose manufacturers, contract packagers, and distribution channels) cannot be completed with citable accuracy from the available information.
- No Orange Book, patent, or litigation-driven inference can be used here to name suppliers.
FAQs
-
Who is the approved NDA holder for Doryx MPC?
Not stated from the available information.
-
Which companies make doxycycline hyclate delayed-release tablets comparable to Doryx MPC?
Not stated from the available information.
-
Are there authorized generics for Doryx MPC that indicate additional suppliers?
Not stated from the available information.
-
Do MPC-coated doxycycline products have separate formulation-specific suppliers?
Not stated from the available information.
-
Which countries have locally sourced Doryx MPC supply?
Not stated from the available information.
References
- (No citable sources were provided in the available information.)
